Pergamum Appoints Jørgen Thorball as New Chairman of the Board
Karolinska Development AB and Pergamum AB announced the appointment of Jørgen Thorball as Chairman of the Board of Directors of Pergamum AB. Dr. Thorball has extensive experience including the successful development and commercialization of new products within the pharmaceutical and healthcare industries. The appointment of Dr. Thorball brings a considerable experience in successful corporate deals and M&A transaction from the international pharmaceutical industry, which will significantly strengthen Pergamum's efforts in seeking to commercialize a number of its more advanced biopharmaceutical development projects.
Dr. Thorball has extensive senior executive experience from companies such as Pharmacia and Aventis. At Novozymes as Vice President, Business Development, he established Biotech as a second leg to Novozyme's enzyme business creating a business approaching 150 MEuros. He has also a great deal of experience in establishing and developing new start-up companies within the biotech sector, where his visionary leadership has resulted in some significant achievements. In 1997, Dr. Thorball founded BioGaia Healthcare Sweden and directed the company in the development of a range of products which today represent a multi-million USD revenue stream.
In line with the new appointment, Björn Olander has stepped down from his previous position as Chairman, but will remain a member of Pergamum's Board of Directors.
Other news from the department people
